SMC Ltd. Capacity Update October 2024: Fill/Finish

Our fill-finish capabilities provide essential support throughout all stages of drug development, from technical and development batches to Phase 1 clinical trials and product launch. With an experienced team and a state-of-the-art, cGMP-compliant facility, we are equipped to handle these critical phases. We have 10 MM units of PFS capacity but also offer manual fill/finish services for other presentations such as vials, syringes, cartridges, and custom primary drug containers.

Our facility maintains the highest levels of sterility assurance and quality control, with the capacity to handle small molecules, cytotoxic formulations, large molecules, and a variety of solution viscosities, suspensions, and gels. Additionally, our pilot and analytical laboratories support process development, analytical method transfer, validation, QC release, stability testing, and QP release to clinic. We offer a full suite of services, including analytical services, process development, and sterile filling across multiple formats.